STEPHANIE FIELDS: Open Payments
NPI 1568092708 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$275 in 13 payments from 9 companies in 2025. Trend: 2023 $776 · 2024 $912 · 2025 $275
Food & beverage: $275
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $47 |
| ABBVIE INC. | 2 | $45 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| QOL Medical, LLC | 1 | $26 |
| Lilly USA, LLC | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Organon LLC | 1 | $19 |
| Janssen Biotech, Inc. | 1 | $18 |
Products named: DUPIXENT, XIFAXAN, ENTYVIO, Sucraid, OMVOH, VOQUEZNA, HADLIMA, TREMFYA.
Industry payments across NY — which companies pay providers there.
